SEC CIK 1188898
NORRINGTON LORRIE M
Reported ownership across 3 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CLview stock → | 43,310 | 2026-10-01 |
| EBAYview stock → | 39,555 | 2010-08-06 |
| ADSKview stock → | 9,981 | 2024-12-11 |
Position History — ADSK
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — ADSK
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2024-12-11 | Open-market sale | 1,778 | $305.37 | 9,981 |
| 2024-12-06 | Open-market sale | 1,778 | $305.92 | 11,759 |
| 2024-07-16 | Grant / award | 401 | $0.00 | 12,553 |
| 2024-07-16 | Grant / award | 984 | $0.00 | 13,537 |
| 2023-09-29 | Open-market sale | 2,148 | $209.71 | 12,152 |
| 2023-06-21 | Grant / award | 490 | $0.00 | 13,098 |
| 2023-06-21 | Grant / award | 1,202 | $0.00 | 14,300 |
| 2022-06-16 | Grant / award | 1,521 | $0.00 | 12,608 |
| 2022-06-16 | Grant / award | 620 | $0.00 | 11,087 |
| 2021-12-30 | Open-market sale | 600 | $280.01 | 14,797 |
| 2021-12-30 | Open-market sale | 1,250 | $281.19 | 13,547 |
| 2021-12-30 | Open-market sale | 3,080 | $282.46 | 10,467 |
| 2021-06-16 | Grant / award | 372 | $0.00 | 14,484 |
| 2021-06-16 | Grant / award | 913 | $0.00 | 15,397 |
| 2020-09-21 | Open-market sale | 2,475 | $220.80 | 14,112 |
| 2020-06-18 | Grant / award | 428 | $0.00 | 15,537 |
| 2020-06-18 | Grant / award | 1,050 | $0.00 | 16,587 |
| 2019-06-12 | Grant / award | 1,526 | $0.00 | 15,109 |
| 2019-06-12 | Grant / award | 622 | $136.66 | 13,583 |
| 2018-08-29 | Open-market sale | 5,001 | $156.75 | 12,961 |
| 2018-06-12 | Grant / award | 1,820 | $0.00 | 17,962 |
| 2018-06-12 | Grant / award | 655 | $0.00 | 16,142 |
| 2017-12-28 | Open-market sale | 6,005 | $104.40 | 15,487 |
| 2017-09-28 | Option exercise (derivative) | 25,000 | $0.00 | 0 |
| 2017-09-28 | Option exercise | 25,000 | $43.81 | 46,492 |
| 2017-09-28 | Open-market sale | 896 | $111.74 | 21,492 |
| 2017-09-28 | Open-market sale | 24,104 | $111.10 | 22,388 |
| 2017-06-29 | Option exercise (derivative) | 25,000 | $0.00 | 25,000 |
| 2017-06-29 | Open-market sale | 5,302 | $102.52 | 21,790 |
| 2017-06-29 | Open-market sale | 298 | $103.57 | 21,492 |
| 2017-06-29 | Open-market sale | 7,000 | $100.95 | 39,492 |
| 2017-06-29 | Option exercise | 25,000 | $43.81 | 46,492 |
| 2017-06-29 | Open-market sale | 12,400 | $101.76 | 27,092 |
| 2017-06-14 | Grant / award | 847 | $0.00 | 19,138 |
| 2017-06-14 | Grant / award | 2,354 | $0.00 | 21,492 |
| 2017-03-07 | Open-market sale | 5,518 | $82.48 | 18,291 |
| 2016-06-15 | Grant / award | 4,416 | $0.00 | 23,809 |
| 2016-06-15 | Grant / award | 1,589 | $0.00 | 19,393 |
| 2016-06-15 | Open-market sale | 5,000 | $56.00 | 17,804 |
| 2015-11-20 | Open-market sale | 5,822 | $60.55 | 22,804 |
| 2015-06-10 | Grant / award | 4,547 | $0.00 | 28,626 |
| 2015-06-10 | Grant / award | 2,183 | $0.00 | 24,079 |
| 2014-11-25 | Open-market sale | 5,822 | $61.29 | 21,896 |
| 2014-06-10 | Grant / award | 8,300 | $0.00 | 27,718 |
| 2014-06-10 | Grant / award | 2,218 | $0.00 | 19,418 |
| 2014-01-02 | Open-market sale | 6,734 | $48.94 | 17,200 |
| 2013-06-13 | Grant / award | 3,344 | $0.00 | 15,634 |
| 2013-06-13 | Grant / award | 8,300 | $0.00 | 23,934 |
| 2012-06-07 | Grant / award | 8,300 | $0.00 | 12,290 |
| 2012-06-07 | Grant / award | 2,756 | $0.00 | 3,990 |
| 2011-06-16 | Grant / award | 1,234 | $0.00 | 1,234 |
| 2011-03-24 | Grant / award (derivative) | 50,000 | $0.00 | 50,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.